# Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

> **NCT00008203** · PHASE3 · COMPLETED · sponsor: **Herbert Irving Comprehensive Cancer Center**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** recombinant interferon gamma
- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** thiotepa
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00008203
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-05
- **Primary completion:** 2005-12
- **Final completion:** 2008-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008203, "Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00008203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*